Nextgen (NXGN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nextgen (NXGN) has a cash flow conversion efficiency ratio of 0.111x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.08 Million ≈ $-2.90K USD) by net assets (ILA-9.72 Million ≈ $-26.05K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Nextgen for the company's overall valuation and market capitalisation.
Nextgen - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Nextgen's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nextgen Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nextgen ranked by their cash flow conversion efficiency. See how well can Nextgen service its debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Uniinfo Telecom Services Limited
NSE:UNIINFO
|
0.029x |
|
MUZHU MINING LTD
F:Y33
|
N/A |
|
Invinity Energy Systems PLC
LSE:IES
|
-0.083x |
|
Range International Ltd
AU:RAN
|
-0.672x |
|
JZ Capital Partners Ltd
LSE:JZCP
|
0.125x |
|
Real Messenger Corporation Ordinary Shares
NASDAQ:RMSG
|
-0.084x |
|
MEP Infrastructure Developers Limited
NSE:MEP
|
-0.376x |
|
Margaret Lake Diamonds Inc
V:DIA
|
0.054x |
Annual Cash Flow Conversion Efficiency for Nextgen (2013–2024)
The table below shows the annual cash flow conversion efficiency of Nextgen from 2013 to 2024. View today's stock price for Nextgen for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA-2.46 Million ≈ $-6.61K |
ILA-2.06 Million ≈ $-5.53K |
0.837x | -81.41% |
| 2023-12-31 | ILA-979.00K ≈ $-2.62K |
ILA-4.41 Million ≈ $-11.81K |
4.499x | +2102.13% |
| 2022-12-31 | ILA12.25 Million ≈ $32.84K |
ILA-2.75 Million ≈ $-7.38K |
-0.225x | -75.07% |
| 2021-12-31 | ILA20.71 Million ≈ $55.51K |
ILA-2.66 Million ≈ $-7.13K |
-0.128x | +42.64% |
| 2020-12-31 | ILA6.87 Million ≈ $18.41K |
ILA-1.54 Million ≈ $-4.12K |
-0.224x | +77.11% |
| 2019-12-31 | ILA1.17 Million ≈ $3.14K |
ILA-1.15 Million ≈ $-3.07K |
-0.978x | -88.16% |
| 2018-12-31 | ILA2.39 Million ≈ $6.40K |
ILA-1.24 Million ≈ $-3.33K |
-0.520x | -14.45% |
| 2017-12-31 | ILA3.66 Million ≈ $9.81K |
ILA-1.66 Million ≈ $-4.45K |
-0.454x | -54.05% |
| 2016-12-31 | ILA5.13 Million ≈ $13.76K |
ILA-1.51 Million ≈ $-4.06K |
-0.295x | +87.25% |
| 2015-12-31 | ILA1.74 Million ≈ $4.65K |
ILA-4.01 Million ≈ $-10.76K |
-2.312x | -162.46% |
| 2014-12-31 | ILA-884.00K ≈ $-2.37K |
ILA-3.27 Million ≈ $-8.77K |
3.702x | +205.08% |
| 2013-12-31 | ILA342.00K ≈ $916.89 |
ILA-1.21 Million ≈ $-3.23K |
-3.523x | -- |
About Nextgen
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.